News

Firm Secures Significant PTAB Win for Novo Nordisk’s Blockbuster Diabetes and Obesity Treatment Drug

October 2, 2023 – Groombridge, Wu, Baughman & Stone successfully defended Novo Nordisk before the Patent Trial and Appeal Board against Mylan Pharmaceuticals in inter partes review (IPR) proceedings seeking to invalidate two Novo patents relating to its blockbuster semaglutide family of drugs, including Ozempic®, Wegovy®, and Rybelsus® (U.S. Patents Nos. 8,536,122 and 8,129,343).  The …

Read more

Firm Wins a Major Victory on Behalf of Genentech

Groombridge, Wu, Baughman & Stone LLP won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough Hemophilia A treatment, HEMLIBRA® (emicizumab-kxwh), which has transformed the lives of thousands of patients.  The U.S. District Court for the District of Delaware …

Read more

Groombridge, Wu, Baughman & Stone LLP、東京丸の内に初の海外拠点をオープン

Groombridge, Wu, Baughman & Stone LLP (GWBS) はこの度東京に新オフィスを開設しました。米国における知的財産関連の案件 (ライセンス、訴訟、知財戦略に関するカウンセリング等) につき、東京在住の外国法事務弁護士マックスウェル (マック)・フォックスが日本のクライアントを全面的にサポートします。東京オフィスは9か月前に開設したGWBSのニューヨーク、ワシントンDCオフィスに次ぐ3番目の拠点となります。 Groombridge, Wu, Baughman & Stone LLPが東京オフィスを設立 – グローバル展開に向けた初の海外進出 | PR TIMES

Firm Opens First Overseas Office in Marunouchi, Tokyo

Groombridge, Wu, Baughman & Stone LLP proudly announces the opening of its newest office, in Tokyo.  The office will represent Japan-based clients in intellectual property disputes in the United States, and is led by prominent Japan-based U.S. patent litigator Maxwell (“Mac”) Fox. This is the third office for our patent litigation firm, which launched a little more than nine …

Read more

Firm Shortlisted by LMG Life Sciences

We are honored to be named on the LMG Life Sciences 2023 Americas Awards shortlist of “Firms to Watch – United States.” Shortlist: https://www.lmglifesciences.com/Stub/AwardsShortlistsNorthAmerica

Firm Lawyers Speak on an AABANY Panel

Together with the Asian-American Bar Association of New York’s Student Outreach Committee (SOC), we hosted a panel on July 10, 2023 with partner Josephine Young and associates Chih-wei Wu and Chieh-Ming (Ben) Hsu, moderated by partner Jennifer Wu and Morvillo Abramowitz Grand Iason & Anello PC partner Karen R. King.  The panelists shared advice about their career paths, law firms, and what it means to …

Read more

Nick Groombridge Speaks at the FCBA’s 2023 Bench & Bar Conference

Partner Nick Groombridge co-moderated a panel on “Patent Remedies” on June 30, 2023 at the Federal Circuit Bar Association’s 2023 Bench & Bar Conference. The panelists, the Honorable Colm Connolly (D. Del.), the Honorable Rodney Gilstrap (E.D. Tex.), and the Honorable Clark S. Cheney (ITC), discussed the procedural, practical, and policy concerns that come into play when requesting, enforcing, …

Read more

Josephine Young Speaks at the ACI’s 14th Summit on Biosimilars & Innovator Biologics

Partner Josephine Young spoke at a panel on June 28, 2023 at the American Conference Institute’s 14th Summit on Biosimilars & Innovator Biologics, titled “Biologics Ethics Module: Understanding the Duties of Disclosure and Reasonable Inquiry.”  The panel discussed the duties of disclosure and reasonable inquiry, strategies for timing USPTO and FDA submissions, acceptable access to samples of the reference …

Read more

Megan Raymond Speaks at the FCBA’s 2023 Bench & Bar Conference

Partner Megan Raymond spoke on July 1, 2023 on the PTAB panel at the Federal Circuit Bar Association’s 2023 Bench & Bar Conference.  Along with her co-panelists, she discussed recent rulemaking proposals, updated strategies for petitioners and patent owners, and real party-in-interest issues.